The DOI matches its Crossref record; 231 of the 231 references it cites were found in a registry or an index.
Drugging the efferocytosis process: concepts and opportunities
Open accessAbstract
The daily removal of billions of apoptotic cells in the human body via the process of efferocytosis is essential for homeostasis. To allow for this continuous efferocytosis, rapid phenotypic changes occur in the phagocytes enabling them to engulf and digest the apoptotic cargo. In addition, efferocytosis is actively anti-inflammatory and promotes resolution. Owing to its ubiquitous nature and the sheer volume of cell turnover, efferocytosis is a point of vulnerability. Aberrations in efferocytosis are associated with numerous inflammatory pathologies, including atherosclerosis, cancer and infections. The recent exciting discoveries defining the molecular machinery involved in efferocytosis have opened many avenues for therapeutic intervention, with several agents now in clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“efferocytosis in other settings can promote fibrosis as part of the tissue resolution process, for example, by secreting TGF-β1 (12, 13).”
From Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction–associated steatohepatitis (2025) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While some progress has been made with respect to the Fractalkine receptor (CX3C motif chemokine receptor 1), Axl, MerTK, CD47 and Tim4/3, no approaches have thus far been clinically approved (64).”
From Cholesterol efflux protein, ABCA1, supports anticancer functions of myeloid immune cells (2026) · cites this paper as [64]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The accumulation of dead cells in disease settings indicates impaired clearance of dead cells by macrophages (“efferocytosis”) (12, 13).”
From Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction–associated steatohepatitis (2025) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“Efferocytosis not only prevents dead cell accumulation but also reprograms macrophages to execute tissue resolution functions, and impaired efferocytosis contributes to many human chronic inflammatory diseases (12, 13).”
From Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction–associated steatohepatitis (2025) · cites this paper as [13]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“It is seen as a major hurdle to using antigen presenting cells in cell-based therapies (61–64).”
From Cholesterol efflux protein, ABCA1, supports anticancer functions of myeloid immune cells (2026) · cites this paper as [64]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Tan, X., Zhang, Z., Yao, H., & Shen, L. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.08.012 · Cited by 76
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease
Cappello, V., Marchetti, L., Parlanti, P., Landi, S., Tonazzini, I., Cecchini, M., Piazza, V., & Gemmi, M. (2016) · Scientific Reports · doi:10.1038/s41598-016-0001-8 · Cited by 13,097
The trinity of COVID-19: immunity, inflammation and intervention
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0311-8 · Cited by 4,360
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1256 · Cited by 3,414
Fadok, V. A., Voelker, D. R., Campbell, P. A., Cohen, J., Bratton, D. L., & Henson, P. M. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.7.2207 · Cited by 3,321
Immunogenic Cell Death in Cancer Therapy
Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303
Immunogenic cell death in cancer and infectious disease
Galluzzi, L., Buqué, A., Kepp, O., Zitvogel, L., & Kroemer, G. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.107 · Cited by 3,119
Research works printed but not linked: 4
- Urbani, L. et al. in Transplantation Proceedings 1175–1178 (Elsevier, 2004).
- Dalli, J., Colas, R., Shinohara, M. & Serhan, C. N. Aging delays resolution of acute inflammation in mice: reprogramming the host response with novel nano-proresolving. Medicines 193, 4235–4244 (2014).
- Noelia, A. et al. Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity 31, 245–258 (2009). This important study highlights the role of nuclear receptors in anti-inflammatory effects of efferocytosis and plausible therapeutic advantages of targeting the pathway. · DOI
- Bohan, D. et al. Targeting the receptor AXL by bemcentinib prevents SARS-CoV-2 infection. Top. Antivir. Med. 29, 137–138 (2021).
Cited by
Sorted by citations
Items 301–400 of 475
Dave, M., Dev, A., Somoza, R. A., Zhao, N. J., Viswanath, S. E., Mina, P. R., Chirra, P. V., Obmann, V. C., Mahabeleshwar, G. H., Menghini, P., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.22.541829 · Cited by 2
Mytych, J. S., Pan, Z., Lopez-Davis, C., Redinger, N., Lawrence, C., Ziegler, J., Popescu, N. I., James, J. A., & Farris, A. D. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.30.535001 · Cited by 2
Márquez-Ropero, M., Valero, J., Cuesta‐Puente, X., Márquez-Galera, Á., Pereira‐Iglesias, M., Louail, A., González-Domínguez, M., Beccari, S., Lopez-Murillo, L., Juan, A. S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.18.676800 · Cited by 2
Gao, H., Li, J., Huang, J., & Jiang, X. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1478827 · Cited by 1
Mittal, Y., Kumar, P., Joshi, K., & Aran, K. R. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01777-z · Cited by 1
Li, M., Xiao, S., Qin, Q., Fu, K., Wang, L., Li, X., Shu, C., & Li, J. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152589 · Cited by 1
Jenkins, S. J., & Gregory, C. D. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-92785-0_6 · Cited by 1
In vivo colonic epithelial cell editing attenuates intestinal inflammation in mice
Zhang, H., Lu, H., Zhang, S., Hu, X., Qixing, W., Yu, Z., Lienanto, N. K., & Zhang, J. (2026) · Inflammation Research · doi:10.1007/s00011-026-02266-x · Cited by 1
Gao, L., Xinying, G., Qin, J., Ziwen, S., Xingrong, S., & Lei, P. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115599 · Cited by 1
Liu, S., Dang, L., Guo, X., Wu, K., Qu, X., Xu, J., Wu, B., & Chen, Z. (2025) · International Dental Journal · doi:10.1016/j.identj.2025.103968 · Cited by 1
Sacrificing cells of the cyst: non-apoptotic cell death in germline cysts via acidification
Bandyadka, S., Tohline, L., Wandji, G.-V., Toledano, H., & McCall, K. (2025) · Frontiers in Cell Death · doi:10.3389/fceld.2025.1677498 · Cited by 1
Jafari, S., & Ghasemi, S. (2025) · Cancer Reports · doi:10.1002/cnr2.70370 · Cited by 1
Wu, L., Yao, H., Wang, Y., Liu, H., Lv, H., Jiao, D., & Jiang, J. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.12.009 · Cited by 1
Qiu, Y.-Y., Wang, Z., He, L., Shi, G.-G., Li, Z.-Z., Ma, S.-X., Yu, D. N., Du, H., Xie, F., Zhang, C., et al. (2025) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2025.101511 · Cited by 1
Systemic Lupus Erythematosus: Emerging Insights into Diagnosis, Treatment, and Prognosis
Kumbhare, M. R., Narkhede, H. I., Chandak, S. M., & Dukare, A. B. (2025) · Journal of Bio-X Research · doi:10.34133/jbioxresearch.0070 · Cited by 1
Neuropeptide INS-14 modulates apoptotic cell clearance in Caenorhabditis elegans
Xie, Y., CHEN, L., Liu, F., Zheng, Q., Yuan, L., Xiao, H., & Wang, H. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.153337 · Cited by 1
Fei, H., Mei, Y., He, J., Li, Y., Xu, R., Liu, W., & Yu, Z. (2026) · Immunology Letters · doi:10.1016/j.imlet.2026.107146 · Cited by 1
Zhang, H., Li, W., Xiao, P., Lu, Z., Tian, Y., & Xu, Y. (2026) · The Journal of Pathology · doi:10.1002/path.70031 · Cited by 1
Mahmoud, A. H., Olivieri, M. A. C., Bannantine, J. P., & Abdellrazeq, G. S. (2026) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiag033 · Cited by 1
Pan, H., Zhang, M., Chen, L., Zhu, H., Huang, S., Huang, Y., Li, Y., Liu, Z., Li, X., & Liu, C. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103119 · Cited by 1
Chen, Q., Liu, C., Wang, Q., Zhang, X., Zheng, Y., Guo, M., & Wang, J. (2026) · Molecular Immunology · doi:10.1016/j.molimm.2026.04.006 · Cited by 1
Endothelial MerTK impairment promotes cardiac dysfunction in the condition of high fat diet
Huang, H., Liu, S., Yao, J., Bai, X., Jin, Z., Xue, B., Shi, H., & Ding, Z. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104184 · Cited by 1
Guo, X., Liu, Y., Li, T., An, X., Song, Y., Xu, P., Huang, J., Zou, Y., Xu, B., Xie, Y., et al. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02641-4 · Cited by 1
Efferocytosis: Signaling Pathways and New Therapeutic Strategies for Diseases
Wang, L., Ge, J., Wang, Z., Fang, Y., Jia, Y., Zhang, R., & Qin, Y. (2026) · MedComm · doi:10.1002/mco2.70764 · Cited by 1
Chu, L., Zhang, L., Liu, X., Zhu, Q. S., Dong, X., Yuan, C., Chen, W., Xu, X., Pan, J., Lu, G., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104421 · Cited by 1
Zheng, H., Liang, Y., & Tian, Y. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04652-3 · Cited by 1
Defective efferocytosis in diabetes: molecular mechanisms and emerging therapeutic strategies
Lei, Y., Tang, M., Deng, H., Li, Y., Wu, J., Luo, L., Mou, Y., 吴千石, Li, Q., Xu, Y., et al. (2026) · Inflammation Research · doi:10.1007/s00011-026-02302-w · Cited by 1
Inflammation in atherosclerosis: Drivers, mechanisms and therapies
Su, Z., & Xu, S. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.06.047 · Cited by 1
Myeloid Cell-Specific Deletion of LGR4 Suppresses Atherosclerotic Lesion Formation
Kathuria, I., Aithabathula, R. V., Mamun, M. A. A., Pervaiz, N., Neeli, I., Ofosu‐Boateng, M., Singh, U. P., Rairao, S., Gyamfi, M. A., Kim, K., et al. (2026) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.324159 · Cited by 1
Chen, L., Liu, Y., Chen, Y., Zhang, Y., Yu, L., Zhu, Y., Peng, W., Wu, M., & Zheng, X. (2026) · Inflammation Research · doi:10.1007/s00011-026-02329-z · Cited by 1
Song, J., Zhu, Y., Zhang, Y., Song, B., Liu, L., Song, Y., Shi, Y., Jiao, Y., Dang, J., Yu, Z., et al. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.179531 · Cited by 1
Huang, T., Qiu, Z., Yang, X., Zhang, H., Zhang, Z., Fang, J., Tu, M., & Wang, Y. (2026) · Acta Biomaterialia · doi:10.1016/j.actbio.2026.08.010 · Cited by 1
Xue, J., Wang, Z., Zhang, X., Xu, S., Wu, S., Sun, X., Li, M., Wu, X., 陈张铭, & Lu, M.-L. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-09320-w · Cited by 1
Zheng, F., Wang, Z., Dong, Q., Li, S., Xiong, S., Yuan, Y., Xu, S., & Fu, B. (2024) · Biochemical Genetics · doi:10.1007/s10528-024-10924-0 · Cited by 1
Tailored platelet biomimetic delivery platform for targeted therapy of inflammatory bowel disease
Li, Y., Zhang, Y., Ding, X., Zou, T., Li, H., Xu, K., Su, C., Wang, Y., Zhao, Z., & He, Y. Z. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.166357 · Cited by 1
LGALS2 and EGR1: markers of endometriosis for predictive, preventive and personalized medicinePreprint
Jiang, H., Sun, Q., Huang, Z., Chen, H., Chen, L., & He, X. (2023) · Research Square · doi:10.21203/rs.3.rs-2726180/v1 · Cited by 1
Lee, Y., Choi, C., Jeong, Y. L., Kim, M., Choi, G., Namgoong, S., Jung, Y. S., Granneman, J. G., Chung, Y., Kim, J. K., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2757116/v1 · Cited by 1
Gordon, H., Gan, D., Dolojan, A., Dennen, J., Hoover, C. A., Koh, Z. M., Chau, K., Arceo, R. A., Cavanaugh, C. J., Li, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.21.689277 · Cited by 1
Zhang, S., Zhao, X., Liu, L., Fang, J., Liu, W., & Zhang, H. (2023) · Research Square · doi:10.21203/rs.3.rs-2661427/v1
Sun, Y., Zhang, Y., Wu, F., & Liu, X. (2023) · Research Square · doi:10.21203/rs.3.rs-2702947/v1
Older and wiser: The benefits to neonates of aged neutrophils
Collins, G. B., & Gilroy, D. W. (2023) · Immunity · doi:10.1016/j.immuni.2023.05.012
Le rôle de la glutaminolyse hépatique dans l'athérosclérose
Murcy, F. (2022) · theses.fr (ABES) · doi:10.70675/44b3f806z6a80z4ecaza5c9z72f5b5ada97d
Murugan, R., & Prasad, M. (2024) · Oral Oncology Reports · doi:10.1016/j.oor.2024.100565
Shen, Y., Liu, X., Li, C., Fan, Y., Zhou, Z.-Y., Xiu, W., Tang, B., Wang, L., Song, H., Tang, J., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4420177/v1
Identification of Key Efferocytosis-Related Genes and Mechanisms in Diabetic Retinopathy
Yu, Q., & Jia, Y. (2024) · Molecular Biotechnology · doi:10.1007/s12033-024-01239-x
Role of Efferocytosis in Health and Diseases
Abbasi, M. H., Shehzadi, N., Safdar, A., Aslam, R., Tariq, A., Shahid, M., Zafar, A., Sheikh, N., & Khawar, M. B. (2024) · Albus Scientia · doi:10.56512/as.2024.1.e240518
Wang, J., Kanmani, P., & Hu, G. (2024) · The Journal of Immunology · doi:10.1093/jimmun/vkag109
Nanomaterials‐Induced Pyroptosis and Immunotherapy
Chen, H., Ding, B., Lin, J., & Ma, P. (2025) · Wiley eBooks · doi:10.1002/9783527845347.ch11
Efferocytosis and retinal clean-up: Role of histone deacetylase 3 in ischemic retinopathy
Fouda, A. Y., & Shosha, E. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01342
A cancer vaccine factory based on autophagy and efferocytosis to enhance tumor immunotherapy
Wang, Y., Wang, T., Jiang, T., Wang, B., Su, Y., Gan, T., & Zhao, X. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.164943
Wu, Y., Zhao, L., Yi, D., Tian, Z., Dong, B., Ye, C., Liu, J., Ma, H., & Zhao, W. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl40818
Park, J. Y., McCaw, T. R., Dao, H., Donahue, T. R., Crompton, J., Vlashi, E., & Girgis, M. D. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.12.669943
Qiu, L., Dang, J., Qiao, J., Zhang, X., Yi, C., & Zhang, X. (2025) · Materials & Design · doi:10.1016/j.matdes.2025.114768
Extracellular matrices regulate extravasation journey of leukocytes and inflammatory tissue fatePreprint
Li, Y. (2025) · eLife · doi:10.7554/elife.108284.1
Metabolic Implications of Efferocytosis During Inflammation
Namgaladze, D., Brüne, B., & Weigert, A. (2025) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-92785-0_4
Sierra, A., Márquez-Ropero, M., Valero, J., Cuesta‐Puente, X., Márquez-Galera, Á., Pereira‐Iglesias, M., González-Domínguez, M., Louail, A., Beccari, S., Murillo, L. L., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-7743374/v1
Role of efferocytosis in liver transplantation via hepatic macrophage
Zhao, M., Xu, X., Peng, H., Tang, C., Luo, J., Liu, J., Liu, Z., Gong, J., Gong, J., & Li, J. (2025) · Molecular Immunology · doi:10.1016/j.molimm.2025.10.003
Yuan, X., Hu, J., Li, N., He, P., Wang, D., Liu, Y., & Yajuan, L. (2025) · Medicine · doi:10.1097/md.0000000000045324
Qiao, F., van der Windt, D. J., Morinelli, T., Zhai, Y., & Scalea, J. R. (2025) · Experimental and Clinical Transplantation · doi:10.6002/ect.2025.0173
Extracellular matrices regulate extravasation journey of leukocytes and inflammatory tissue fatePreprint
Li, Y. (2025) · eLife · doi:10.7554/elife.108284.2
Gazzar, W. B. E., Farag, A. A., Bayoumi, H., Radwaan, S. E., Mohammed, L. A., Nasr, H. E., Ahmed, N. E., Ibrahim, R. M., Mostafa, M., Mohamed, S. K., et al. (2025) · Biomolecules · doi:10.3390/biom15121709
Shi, B., Deng, M., Ma, J., Chen, C., Peng, A., Zhu, A., Yang, R., Jin, Z., Zhu, J., Zhang, M., et al. (2025) · Mediators of Inflammation · doi:10.1155/mi/8710699
Pokushalov, E. A., Garcia, C., Smith, J., Kudlay, D. A., Revkov, N., Shcherbakova, A., Johnson, M., & Miller, R. D. (2025) · Veterinary World · doi:10.14202/vetworld.2025.3914-3928
Harnessing Apoptosis to Guide in Situ Remodeling of Tissue Engineered Heart ValvesPreprint
Breitenstein, P., Martin, M., Visser, V. L., Motta, S. E., Emmert, M. Y., & Hoerstrup, S. P. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.5049299
Zhang, J., He, Z., Xiong, C., Yao, Y., Zhang, C., Yao, W., Yang, S., Li, X., & Han, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26066058
Liao, Y.-S., Zhang, T., Tang, Y.-Q., Yu, P., Liu, Y., Yuan, J., & Zhao, L. (2024) · Figshare · doi:10.6084/m9.figshare.26945079
Liao, Y.-S., Zhang, T., Tang, Y.-Q., Yu, P., Liu, Y., Yuan, J., & Zhao, L. (2024) · Figshare · doi:10.6084/m9.figshare.26945100
Liao, Y.-S., Zhang, T., Tang, Y.-Q., Yu, P., Liu, Y., Yuan, J., & Zhao, L. (2024) · Figshare · doi:10.6084/m9.figshare.26945091
Liao, Y.-S., Zhang, T., Tang, Y.-Q., Yu, P., Liu, Y., Yuan, J., & Zhao, L. (2024) · Figshare · doi:10.6084/m9.figshare.26945097
Ma, Z., Sun, Y., Yu, Y., Xiao, W., Xiao, Z., Zhong, T., Xiang, X., & Li, Z. (2024) · Figshare · doi:10.6084/m9.figshare.25909927
Liao, Y.-S., Zhang, T., Tang, Y.-Q., Yu, P., Liu, Y., Yuan, J., & Zhao, L. (2024) · Figshare · doi:10.6084/m9.figshare.26945085
Ma, Z., Sun, Y., Yu, Y., Xiao, W., Xiao, Z., Zhong, T., Xiang, X., & Li, Z. (2024) · Figshare · doi:10.6084/m9.figshare.26726273
Ma, Z., Sun, Y., Yu, Y., Xiao, W., Xiao, Z., Zhong, T., Xiang, X., & Li, Z. (2024) · Figshare · doi:10.6084/m9.figshare.26726270
Zhang, J., He, Z., Xiong, C., Yao, Y., Zhang, C., Yao, W., Yang, S., Li, X., & Han, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26066179
Zhang, J., He, Z., Xiong, C., Yao, Y., Zhang, C., Yao, W., Yang, S., Li, X., & Han, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26736195
Liao, Y.-S., Zhang, T., Tang, Y.-Q., Yu, P., Liu, Y., Yuan, J., & Zhao, L. (2024) · Figshare · doi:10.6084/m9.figshare.26945082
Ma, Z., Sun, Y., Yu, Y., Xiao, W., Xiao, Z., Zhong, T., Xiang, X., & Li, Z. (2024) · Figshare · doi:10.6084/m9.figshare.25910168
Liao, Y.-S., Zhang, T., Tang, Y.-Q., Yu, P., Liu, Y., Yuan, J., & Zhao, L. (2024) · Figshare · doi:10.6084/m9.figshare.26945088
Liao, Y.-S., Zhang, T., Tang, Y.-Q., Yu, P., Liu, Y., Yuan, J., & Zhao, L. (2024) · Figshare · doi:10.6084/m9.figshare.26945073
Liao, Y.-S., Zhang, T., Tang, Y.-Q., Yu, P., Liu, Y., Yuan, J., & Zhao, L. (2024) · Figshare · doi:10.6084/m9.figshare.26945094
Liao, Y.-S., Zhang, T., Tang, Y.-Q., Yu, P., Liu, Y., Yuan, J., & Zhao, L. (2024) · Figshare · doi:10.6084/m9.figshare.26945070
Liao, Y.-S., Zhang, T., Tang, Y.-Q., Yu, P., Liu, Y., Yuan, J., & Zhao, L. (2024) · Figshare · doi:10.6084/m9.figshare.26945076
Idrus, F. N. M., Al-Ali, H. A. H., Yasin, Z. N. M., Azlan, M., Suppıan, R., Cun, S. T. W., Hoe, C. H., Ahmad, N. S., Yusof, Z., Isa, W. Y. H. W., et al. (2025) · Immuno · doi:10.3390/immuno6010006
Distinct Composition-dependent Biodis-tribution Patterns of Phospholipid Liposomes
Kawano, T., Kang, J., & Murata, M. (2025) · Journal of Oleo Science · doi:10.5650/jos.ess25148
Kang, Y., Qian, J., Zhou, M., Zheng, H., Li, A., Li, D., Wang, X., Zhou, J., Lv, J., & Wang, Y. (2026) · Inflammation · doi:10.1007/s10753-025-02401-6
Alvarez, D. V., Soto, M. A., Perez, R. T., Molina, J. S., Rojas, A. F., & Castro, E. N. (2022) · Journal of Medical Sciences and Interdisciplinary Research · doi:10.51847/z6oxshzvgl
Huang, Z., Weng, X., Tan, H., Li, W., Pang, Z., Jiang, M., Cai, S., Zheng, D., Gao, J., Lin, A., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-8532127/v1
Liquidambaris Fructus Inhibits Osteosarcoma Through PTGS2/TGFB1 And Regulates Efferocytosis.
Deng, L. (2026) · Pakistan Journal of Pharmaceutical Sciences · doi:10.36721/pjps.2026.39.5.reg.13984.1
Zhou, Y., Zhang, Z., Liu, Y., Liu, W., & Dai, J. (2026) · Scientific Reports · doi:10.1038/s41598-026-46752-y
Phagocytosis by human macrophages : modulation by the microenvironment and by human rhinoviruses
Depierre, M. (2024) · theses.fr (ABES) · doi:10.70675/3c2cef44zd5c0z4432z837cz2776a6c2ceb9
Impact de la fièvre sur les capacités d’efferocytose des macrophages murins
Vetter, M. (2024) · theses.fr (ABES) · doi:10.70675/357f2a9az24f2z4eb8z9c65z47cf18914415
Depaire, A. (2024) · theses.fr (ABES) · doi:10.70675/71446f40z049cz46e8z8ec5zabcb6c311248
Ozkocak, D. C., Santavanond, J. P., Tanzer, M. C., & Poon, I. K. H. (2026) · Cell Death Discovery · doi:10.1038/s41420-026-03099-7
Dysregulated Efferocytosis and Immune Microenvironment in High Somatic Cell Count Dairy Cows
Feng, J., Deng, M., Fan, F., Liu, J., Wang, D., & Cai, J. (2026) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/jpn.70066
Microparticle uptake reduces efferocytic capacity of macrophages
Mishra, S., Aggarwal, B., Anant, P. S., Bajaj, A., & Jhunjhunwala, S. (2026) · Biomaterials Science · doi:10.1039/d5bm01447f
Xu, X., Su, T., Sun, Q., Wang, X., Liu, Y., & Wang, H. (2026) · BIO-PROTOCOL · doi:10.21769/bioprotoc.5690
Ngai, D., Chowdhury, S., Sukka, S. R., Kuriakose, G., Havens, B. T., Yalçınkaya, M., Frey, J. M., Doviak, H., Bradford, J. W., Dorweiler, B., et al. (2026) · Nature Communications · doi:10.64898/2026.04.27.720940
Metadata
- Authors
- Mehrotra, P., & Ravichandran, K. S.
- Affiliations
- VIB-UGent Center for Inflammation Research (BE)
- Washington University in St. Louis (US)
- Corresponding author
- Ravichandran, Kodi S.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2022-06-01
- Volume
- 21
- Issue
- 8
- Pages
- 601-620
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- PMC
- PMC9157040
- OpenAlex
- W4281737563
- Cited by
- 459
- References
- 231
- Citations by year
- 2026: 130 · 2025: 153 · 2024: 104 · 2023: 66 · 2022: 6
- FWCI
- 8.88
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL120840)
- National Institute of General Medical Sciences (R35GM122542)
- National Institute of Allergy and Infectious Diseases (R01AI159551)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- efferocytosis, phagocytes, anti-inflammatory mechanism, inflammation resolution, therapeutic target, atherosclerosis, cancer, infection
- MeSH terms
- Homeostasis, Humans, Phagocytes, Phagocytosis, Apoptosis, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
